Podcast: Play in new window | Download
Bilal has presented lectures on leadership, innovation, and his team’s cancer breakthrough at numerous conferences, most notably at the Global Health & Innovation Conference at Yale University attended by over 3,000 people. Bilal holds U.S. Patent #9919016: “Product and method of deploying kale derivatives for anti-cancer effects.” As the CEO of EasyKale Labs, he’s continuing his research into the cancer-fighting properties of kale, while offering a next-generation product for making kale consumption easier—Bilal’s EasyKale.